SS Innovations International Inc. (NASDAQ: SSII) reported record first-quarter 2026 financial results, with revenue surging 116.8% year over year to $11.1 million, driven by accelerating adoption of its SSi Mantra surgical robotic platform. The company's installed base reached 194 systems across 11 countries, and cumulative robotic procedures totaled nearly 9,750 during the quarter, later rising to 11,719 as of June 22, 2026, according to the company's earnings announcement.
The strong performance underscores growing demand for minimally invasive surgical robotics, particularly in emerging markets. SS Innovations secured regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines during the quarter, expanding its international footprint. The company also completed the world's longest-distance robotic cardiac telesurgery, demonstrating the capabilities of its remote surgery platform and positioning it for potential applications in underserved regions.
Gross profit rose sharply to $5.3 million from $1.1 million a year earlier, reflecting improved operational efficiency as procedure volumes increased. The SSi Mantra system has now been used for over 170 different types of procedures, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform, signaling growing clinical acceptance.
SS Innovations continues to pursue regulatory clearance in both the United States and Europe, which would open access to the world's largest healthcare markets. The company's focus on emerging markets provides near-term growth while it prepares for entry into developed regions. The successful telesurgery demonstration highlights the platform's potential to expand access to specialized surgical care across long distances.
The company's financial trajectory and technological advancements are significant for the surgical robotics industry, as SS Innovations challenges established players with a platform designed for cost-effectiveness and versatility. The rapid increase in installations and procedures suggests strong market traction, particularly in countries seeking advanced surgical capabilities without the high costs associated with competing systems.
For more information, visit the company's website at www.SSInnovations.com. Additional details about the company's communications platform can be found at InvestorWire.
